{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T05:53:46Z","timestamp":1721886826238},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/pap.0b013e318271a5cb","type":"journal-article","created":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T14:21:39Z","timestamp":1349965299000},"page":"410-416","source":"Crossref","is-referenced-by-count":13,"title":["Update in Molecular Diagnostics in Melanocytic Neoplasms"],"prefix":"10.1097","volume":"19","author":[{"given":"Chelsea","family":"Cooper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedram","family":"Gerami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210202","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"R2-6-20210202","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1158\/0008-5472.CAN-08-3355","article-title":"BRCA1-associated protein 1 interferes with BRCA1BARD1 RING heterodimer activity.","volume":"69","author":"Nishikawa","year":"2009","journal-title":"Cancer Res"},{"key":"R3-6-20210202","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","article-title":"BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.","volume":"68","author":"Ventii","year":"2008","journal-title":"Cancer Res"},{"key":"R4-6-20210202","doi-asserted-by":"crossref","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","article-title":"The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.","volume":"284","author":"Machida","year":"2009","journal-title":"J Biol Chem"},{"key":"R5-6-20210202","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1093\/emboj\/cdg242","article-title":"Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF-1.","volume":"22","author":"Julien","year":"2003","journal-title":"EMBO J"},{"key":"R6-6-20210202","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors.","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"R7-6-20210202","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma.","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"R8-6-20210202","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"R9-6-20210202","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/PAS.0b013e31822678d2","article-title":"Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings.","volume":"35","author":"Pouryazdanparast","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R10-6-20210202","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1126\/science.1071550","article-title":"G protein pathways.","volume":"296","author":"Neves","year":"2002","journal-title":"Science"},{"key":"R11-6-20210202","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"R12-6-20210202","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/372276a0","article-title":"GTPase mechanism of Gproteins from the 1.7-A crystal structure of transducin alpha-GDP-AIF-4.","volume":"372","author":"Sondek","year":"1994","journal-title":"Nature"},{"key":"R13-6-20210202","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1128\/MCB.12.10.4687","article-title":"Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.","volume":"12","author":"Kalinec","year":"1992","journal-title":"Mol Cell Biol"},{"key":"R14-6-20210202","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"R15-6-20210202","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/ng1412","article-title":"Effects of G-protein mutations on skin color.","volume":"36","author":"Van Raamsdonk","year":"2004","journal-title":"Nat Genet"},{"key":"R16-6-20210202","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma.","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"R17-6-20210202","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1755-148X.2012.00979.x","article-title":"The genetics of uveal melanoma: an emerging framework for targeted therapy.","volume":"25","author":"Harbour","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"R18-6-20210202","first-page":"2170","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.","volume":"58","author":"Bastian","year":"1998","journal-title":"Cancer Res"},{"key":"R19-6-20210202","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":"Classifying melanocytic tumors based on DNA copy number changes.","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"key":"R20-6-20210202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","article-title":"Mutations and copy number increase of HRAS in spitz nevi with distinctive histopathological features.","volume":"157","author":"Bastian","year":"2000","journal-title":"Am J Pathol"},{"key":"R21-6-20210202","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R22-6-20210202","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R23-6-20210202","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/PAS.0b013e3181ba6db6","article-title":"Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R24-6-20210202","first-page":"335","article-title":"Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma.","volume":"38","author":"Gammon","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R25-6-20210202","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/PAS.0b013e3181a92cbc","article-title":"Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.","volume":"33","author":"Pouryazdanparast","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R26-6-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0560.2010.01666.x","article-title":"Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.","volume":"38","author":"Gerami","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R27-6-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/modpathol.3800281","article-title":"Spitz nevi and atypical spitz nevitumors: a histologic and immunohistochemical analysis.","volume":"18","author":"Kapur","year":"2005","journal-title":"Mod Pathol"},{"key":"R28-6-20210202","doi-asserted-by":"crossref","first-page":"313S","DOI":"10.1038\/jid.1993.54","article-title":"Immunophenotyping of compound and spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections.","volume":"100","author":"Lazzaro","year":"1993","journal-title":"J Invest Dermatol"},{"key":"R29-6-20210202","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaad.2008.10.040","article-title":"The superficial atypical spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical spitz tumor: a distinct form of dysplastic spitzoid nevomelanocytic proliferation.","volume":"60","author":"Magro","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R30-6-20210202","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archdermatol.2011.170","article-title":"Long-term outcome of spitz-type melanocytic tumors.","volume":"147","author":"Sepehr","year":"2011","journal-title":"Arch Dermatol"},{"key":"R31-6-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31822d5ff8","article-title":"Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.","volume":"36","author":"Gammon","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R32-6-20210202","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1309\/AJCP52YVYCTLUOPI","article-title":"Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and spitz tumors.","volume":"133","author":"George","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R33-6-20210202","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/modpathol.2010.102","article-title":"The immunohistochemical profile of spitz nevi and conventional (non-spitzoid) melanomas: a baseline study.","volume":"23","author":"Garrido-Ruiz","year":"2010","journal-title":"Mod Pathol"},{"key":"R35-6-20210202","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0046-8177(99)90193-4","article-title":"Atypical spitz nevitumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.","volume":"30","author":"Barnhill","year":"1999","journal-title":"Hum Pathol"},{"key":"R36-6-20210202","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1996.14.4.1218","article-title":"Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions.","volume":"14","author":"Corona","year":"1996","journal-title":"J Clin Oncol"},{"key":"R37-6-20210202","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/modpathol.2010.228","article-title":"Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.","volume":"24","author":"Vergier","year":"2011","journal-title":"Mod Pathol"},{"key":"R38-6-20210202","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jaad.2010.05.043","article-title":"Atypical spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.","volume":"64","author":"Massi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R39-6-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/modpathol.2009.177","article-title":"Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.","volume":"23","author":"Gaiser","year":"2010","journal-title":"Mod Pathol"},{"key":"R40-6-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PAS.0b013e31820393ee","article-title":"Copy number variations and clinical outcome in atypical spitz tumors.","volume":"35","author":"Raskin","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R41-6-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/cncr.24047","article-title":"The atypical spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.","volume":"115","author":"Ludgate","year":"2009","journal-title":"Cancer"},{"key":"R42-6-20210202","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmoldx.2011.01.011","article-title":"Copy number gains in 11q13 and 8q24 corrected are highly linked to prognosis in cutaneous malignant melanoma.","volume":"13","author":"Gerami","year":"2011","journal-title":"J Mol Diagn"},{"key":"R43-6-20210202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/PAS.0b013e31823425cc","article-title":"Distinctive clinical and histologic features in cutaneous melanoma with copy number gains in 8q24.","volume":"36","author":"Pouryazdanparast","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R44-6-20210202","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer.","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"R45-6-20210202","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation.","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"R48-6-20210202","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"key":"R49-6-20210202","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00125480-201211000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:00:26Z","timestamp":1618038026000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00125480-201211000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0b013e318271a5cb","relation":{},"ISSN":["1072-4109"],"issn-type":[{"value":"1072-4109","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}